Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:COUR - US22266M1045 - Common Stock

8.02 USD
+0.08 (+1.01%)
Last: 12/17/2025, 2:26:04 PM
Fundamental Rating

5

COUR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 77 industry peers in the Diversified Consumer Services industry. No worries on liquidiy or solvency for COUR as it has an excellent financial health rating, but there are worries on the profitability. COUR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
In the past year COUR had a positive cash flow from operations.
In the past 5 years COUR always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: COUR reported negative operating cash flow in multiple years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -4.60%, COUR perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
COUR has a Return On Equity (-7.16%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.6%
ROE -7.16%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 54.36%, COUR is in the better half of the industry, outperforming 64.94% of the companies in the same industry.
COUR's Gross Margin has been stable in the last couple of years.
COUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

8

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
COUR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for COUR has been increased compared to 5 years ago.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.16 indicates that COUR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of COUR (2.16) is better than 62.34% of its industry peers.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.16
ROIC/WACCN/A
WACC8.82%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.57 indicates that COUR has no problem at all paying its short term obligations.
COUR has a Current ratio of 2.57. This is amongst the best in the industry. COUR outperforms 81.82% of its industry peers.
A Quick Ratio of 2.57 indicates that COUR has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.57, COUR belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 2.57
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.25%, which is quite impressive.
COUR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.10%.
The Revenue has been growing by 30.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)31.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)8.1%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%10.29%

3.2 Future

Based on estimates for the next years, COUR will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.08% on average per year.
COUR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.05% yearly.
EPS Next Y17.21%
EPS Next 2Y15.63%
EPS Next 3Y18.08%
EPS Next 5YN/A
Revenue Next Year8.72%
Revenue Next 2Y7.35%
Revenue Next 3Y7.05%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.10, which indicates a rather expensive current valuation of COUR.
64.94% of the companies in the same industry are more expensive than COUR, based on the Price/Earnings ratio.
COUR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.43.
COUR is valuated rather expensively with a Price/Forward Earnings ratio of 17.64.
Based on the Price/Forward Earnings ratio, COUR is valued a bit cheaper than 66.23% of the companies in the same industry.
COUR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.66, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.1
Fwd PE 17.64
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

74.03% of the companies in the same industry are more expensive than COUR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.19
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

COUR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as COUR's earnings are expected to grow with 18.08% in the coming years.
PEG (NY)1.11
PEG (5Y)N/A
EPS Next 2Y15.63%
EPS Next 3Y18.08%

0

5. Dividend

5.1 Amount

COUR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

COURSERA INC

NYSE:COUR (12/17/2025, 2:26:04 PM)

8.02

+0.08 (+1.01%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-23 2025-10-23/amc
Earnings (Next)01-28 2026-01-28/amc
Inst Owners81.52%
Inst Owner Change5.47%
Ins Owners6.07%
Ins Owner Change-0.95%
Market Cap1.33B
Revenue(TTM)739.78M
Net Income(TTM)-45.81M
Analysts74.29
Price Target12.67 (57.98%)
Short Float %5.83%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.72%
Min EPS beat(2)17.31%
Max EPS beat(2)36.12%
EPS beat(4)4
Avg EPS beat(4)48.89%
Min EPS beat(4)17.31%
Max EPS beat(4)92.38%
EPS beat(8)8
Avg EPS beat(8)1321.29%
EPS beat(12)12
Avg EPS beat(12)907.86%
EPS beat(16)14
Avg EPS beat(16)684.01%
Revenue beat(2)2
Avg Revenue beat(2)0.81%
Min Revenue beat(2)0.03%
Max Revenue beat(2)1.6%
Revenue beat(4)3
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-0.48%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.04%
Revenue beat(12)9
Avg Revenue beat(12)0.94%
Revenue beat(16)12
Avg Revenue beat(16)0.73%
PT rev (1m)0%
PT rev (3m)1.36%
EPS NQ rev (1m)-3.52%
EPS NQ rev (3m)-14.58%
EPS NY rev (1m)0%
EPS NY rev (3m)1.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.06%
Valuation
Industry RankSector Rank
PE 19.1
Fwd PE 17.64
P/S 1.8
P/FCF 15.19
P/OCF 10.93
P/B 2.09
P/tB 2.17
EV/EBITDA N/A
EPS(TTM)0.42
EY5.24%
EPS(NY)0.45
Fwd EY5.67%
FCF(TTM)0.53
FCFY6.59%
OCF(TTM)0.73
OCFY9.15%
SpS4.45
BVpS3.84
TBVpS3.69
PEG (NY)1.11
PEG (5Y)N/A
Graham Number6.03
Profitability
Industry RankSector Rank
ROA -4.6%
ROE -7.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.36%
FCFM 11.88%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 121.61%
Cap/Sales 4.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 2.57
Altman-Z 2.16
F-Score5
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y17.21%
EPS Next 2Y15.63%
EPS Next 3Y18.08%
EPS Next 5YN/A
Revenue 1Y (TTM)8.1%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%10.29%
Revenue Next Year8.72%
Revenue Next 2Y7.35%
Revenue Next 3Y7.05%
Revenue Next 5YN/A
EBIT growth 1Y34.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year267.75%
EBIT Next 3Y77.9%
EBIT Next 5YN/A
FCF growth 1Y1633.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y866.87%
OCF growth 3Y279.12%
OCF growth 5YN/A

COURSERA INC / COUR FAQ

What is the ChartMill fundamental rating of COURSERA INC (COUR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to COUR.


What is the valuation status for COUR stock?

ChartMill assigns a valuation rating of 4 / 10 to COURSERA INC (COUR). This can be considered as Fairly Valued.


How profitable is COURSERA INC (COUR) stock?

COURSERA INC (COUR) has a profitability rating of 2 / 10.


How financially healthy is COURSERA INC?

The financial health rating of COURSERA INC (COUR) is 8 / 10.